First Time Loading...

Magellan Health Inc
NASDAQ:MGLN

Watchlist Manager
Magellan Health Inc Logo
Magellan Health Inc
NASDAQ:MGLN
Watchlist
Price: 94.99 USD Market Closed
Updated: May 18, 2024
Section:
 

Wall Street
Price Targets

MGLN Price Targets Summary
Magellan Health Inc

There are no price targets for MGLN.
MGLN Lowest Forecast
Wall Street Target
Not Available
MGLN Average Forecast
Wall Street Target
Not Available
MGLN Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Magellan Health Inc Competitors:
Price Targets
HAPV3
Hapvida Participacoes e Investimentos SA
31% Upside
UNH
UnitedHealth Group Inc
10% Upside
MOH
Molina Healthcare Inc
19% Upside
ELV
Elevance Health Inc
13% Upside
HAPV3
Hapvida Participacoes e Investimentos SA
31% Upside
UNH
UnitedHealth Group Inc
10% Upside
MOH
Molina Healthcare Inc
19% Upside
ELV
Elevance Health Inc
13% Upside
HQY
Healthequity Inc
29% Upside
PGNY
Progyny Inc
72% Upside
ODPV3
Odontoprev SA
8% Upside

Revenue
Forecast

Revenue Estimate
Magellan Health Inc

For the last 8 years the compound annual growth rate for Magellan Health Inc's revenue is 5%. The projected CAGR for the next 2 years is 8%.

5%
Past Growth
8%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Magellan Health Inc

Operating Income forecast
is not available for
Magellan Health Inc

Net Income
Forecast

Net Income Estimate
Magellan Health Inc

For the last 8 years the compound annual growth rate for Magellan Health Inc's net income is 12%. The projected CAGR for the next 2 years is -52%.

12%
Past Growth
-52%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
MGLN intrinsic value, competitors valuation, and company profile.
DCF Valuation
MGLN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MGLN stock valuation using valuation multiples.
Wall Street Estimates
MGLN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MGLN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MGLN's stock price target?
Not Available

MGLN doesn't have any price targets made by Wall Street professionals.

What is Magellan Health Inc's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Magellan Health Inc's revenue is 5%. The projected CAGR for the next 2 years is 8%.

What is Magellan Health Inc's Net Income forecast?
Projected CAGR
-52%

For the last 8 years the compound annual growth rate for Magellan Health Inc's net income is 12%. The projected CAGR for the next 2 years is -52%.

ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.